1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. Chinook Therapeutics Acquires Aduro Biotech

M&A Deal Summary

Chinook Therapeutics Acquires Aduro Biotech

On October 1, 2020, Chinook Therapeutics acquired life science company Aduro Biotech

Acquisition Highlights
  • This is Chinook Therapeutics’ 1st transaction in the Life Science sector.
  • This is Chinook Therapeutics’ 1st transaction in the United States.
  • This is Chinook Therapeutics’ 1st transaction in California.

M&A Deal Summary
Date 2020-10-01
Target Aduro Biotech
Sector Life Science
Buyer(s) Chinook Therapeutics
Deal Type Merger

Target

Aduro Biotech

Berkeley, California, United States
Aduro Biotech is a clinical-stage immunotherapy company focused on the discovery, development, and commercialization of therapies that transform the treatment of challenging diseases.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Chinook Therapeutics

Seattle, Washington, United States
Category Company
Sector Life Science
Employees105
DESCRIPTION

Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for kidney diseases. The company’s products are focused on rare, severe chronic kidney disorders with opportunities for well-defined and streamlined clinical pathways. Chinook Therapeutics is based in Seattle, Washington.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal